Home > Cluster Organisations > Biopeople, Denmark's Life Science Cluster

Biopeople, Denmark's Life Science Cluster

Primary tabs

Printer-friendly versionPrinter-friendly version
General Information
The date when the cluster organisation was established: 
Friday, 1 April, 2005
Number of staff in the management team of the cluster organisation : 
6-10
Regions: 
Hovedstaden
Cluster Excellence Label: 
Gold Label
Membership to European Strategic Cluster Partnerships (ESCP-4i, ESCP-S3 or ESCP-4x): 
Membership to other networks/partnerships: 
NameWebsite
CEBR - Council of European Bioregions
Health Axis Europe
Copenhagen Centre for Regulatory Science
Samarbejdsplatform for Kvalificeret Arbejdskraft til Produktionsvirksomheder i Region Sjælland
Cluster Management Team: 
NameSurnamePositionTelephoneEmailGender
Per
Spindler
ECCP Responsible Person
+45 28 75 65 72
pesp@biopeople.ku.dk
Male
Randi
Munch Krogsgaard
Cluster Manager
+45 23 83 99 39
randi.krogsgaard@biopeople.ku.dk
Female
Emil
Smedegård-Holmquist
Cluster Manager
+45 20 13 54 59
emilholmquist@rn.dk
Male
Anette
Birck
Cluster Manager
+45 93 56 54 97
anette.birck@sund.ku.dk
Female
Jane
Nøhr
Cluster Manager
+45 93 56 56 06
jane.noehr@biopeople.ku.dk
Female
Rune
Thomsen
Cluster Manager
+45 28 49 80 14
rt@biomed.au.dk
Male
Languages spoken: 
Danish
English
French
German
Norwegian
Spanish
Swedish
Sectoral and Industrial Focus
Sectoral Industries: 
Biopharmaceuticals
Education and Knowledge Creation
Technology fields: 
Medical Technology / Biomedical Engineering
Pharmaceutical Products / Drugs
S3 EU priority areas: 
e-Health (e.g. healthy ageing)
Biotechnology
Emerging industries: 
Biopharmaceuticals
Medical Devices
Areas of specialisation of the cluster not covered above: 
Precision Medicine, biomarkers, x-omics, inflammatory & autoimmune diseases and therapeutics
Composition of the cluster
Total number of members: 
500
Number of SME members: 
150
Number of start-ups among SME members: 
50
Number of larger company members: 
25
Number of research organisations/universities/technology centres: 
25
Number of other ecosystem actors : 
25
Entrepreneurship and scale-up support facilities in the cluster's ecosystem (see "Organisation type"): 
Organisation/Facility NameOrganisation/Facility TypeWebsite
INCUBA
Incubator
COBIS
Incubator
DTI Science Park
Incubator
NOVI
Incubator
BII
Accelerator
Novo Nordisk Fonden
Investor
Lundbeckfonden
Investor
The Kitchen at Aarhus University
Co-working Space
Bioneer
Technology center
The Danish Technological Institute
Technology center
DHI
Technology center
Name and link of major players: 
Cluster Strategy
Mission/Objectives: 

Biopeople is Denmark's Life Science Cluster located at the University of Copenhagen. We are part of the Danish infrastructure for innovation - established and co-funded by the Ministry of Higher Education and Science (innovationsnetværk).

We are a neutral catalyst for collaboration between companies and public research, and our strategic priority is to support the paradigm shift in the health care sector, implying a strengthened focus on biomarkers, companion diagnostics, precision / personalized medicine, regulatory science, and stakeholder involvement, incl. patient and investor communities.

Our priorities are implemented through initiatives and programmes that facilitate companies and entrepreneurs becoming part of the international industry value chain, and through programmes that enhance public-privat and cross-disciplinary collaborations.

We build competences and value in collaboration with educational institutions and companies that leads to increase in job and export.

Our cluster partnership embed all major public and private research and education in Denmark, a large number of private companies plus the Danish Medicines Agency.

We were the first international Life Science cluster in 2013 to achieve the Gold Label of the European Secretariat for Cluster Analysis (ESCA /ESCARD) as supported by the EU Commission.

Our vision Danish Life Science grows through innovation and collaboration

Our mission Biopeople facilitates confidence-building  interpersonal relations. This is to fulfill  the needs of our stakeholders for strengthening innovation through cross disciplinary and international partnerships.

We focus on

  • Catalyzing innovation by creating inspiring meeting places for public and private stakeholders within Life Sciences
  • Inspiring to cross disciplinary collaboration and partnership bringing smaller companies, public/private synergy and internationalization into the spotlight
  • Supporting the development of professional competences within especially internationalization, innovation and foresight
Do you have a formalised strategy?: 
Yes
Do you have a specific strategy focus that addresses internationalisation ?: 
Yes
Services
Support services provided: 
Access to public support (regional/national programmes, innovation vouchers, etc.)
Access to private funding (connecting to investors, seed-capital, venture-capital, crowd-funding, etc.)
Facilitation of collaboration between members
Facilitation of cross-sectorial cooperation
Support of knowledge transfer
Details of support services: 
  • Catalyzing innovation by creating inspiring meeting places for public and private stakeholders within Life Sciences
  • Inspiring to cross disciplinary collaboration and partnership bringing smaller companies, public/private synergy and internationalization into the spotlight
  • Supporting the development of professional competences within especially internationalization, innovation and foresight
Cooperation Activities
International Cooperation
The main countries targeted by the cluster organisation: 
Israel
Our cluster organisation undertook the following international activities to support our members: 
Support to collaborative activities/etc.
Trans-national Cooperation
The main countries targeted by the cluster organisation: 
Belgium
France
Germany
Netherlands
United Kingdom
Our cluster organisation undertook the following trans-national activities to support our members: 
Support to collaborative activities/etc.
Which clusters do you collaborate with?: 
BioRN (Germany)
ATLANPOLE BIOTHERAPIES(France)
BioCon Valley (Germany)
Turku Science Park (Finland)
Tartu Technology Park (Estonia)
Wroclaw Technology Park (Poland)
Brightlands and Chemelot Campus (The Netherlands)
K.U. Leuven Research & Development (Belgium)
BIOCAT (Spain)
BIOREGIO STERN MANAGEMENT GMBH (Germany)
EURASANTÉ (France)
GROWTH COMPANY LTD (United Kingdom)
ID2SANTÉ (France)
INTERFACE ENTREPRISES-ULIÈGE (Belgium)
KENT COUNTY COUNCIL (United Kingdom)
NOORD-BRABANT DEVELOPMENT AGENCY (BOM) (The Netherlands)
OOST NL (The Netherlands)
Medicon Valley Alliance (Denmark-Sweden)
Support Programmes
Participation in Funded Support Programmes: 
European ProgrammesProject NameName & Description (Regional/National)
H2020
CIP/COSME
INTERREG
EIT KICs
Other

CELIS, Cluster Excellence in Life Sciences’ provides financial support for international exchanges (European Strategic Cluster Partnerships for Excellence (ESCP-4X) selected under the last call for proposals of the European Cluster Excellence Programme (COS-CLUSTER-2018-03-02).

Boost4health, Interreg NWE

Biomarker Commercialisation (BiC), Interreg BSR

EFOEUPATI, H2020

Interreg BSR, NWE, Deuthland-Danmark, and others. (e.g. https://biomarker.nu/)

Innovative Medicines Initiative (IMI1 and IMI2) (https://www.imi.europa.eu/projects-results/project-factsheets/efoeupati)

H2020 COSME (e.g. COS-CLUSTER-2018-03-02: European Cluster Excellence Programme)

EIT Health (https://eithealth.eu/project/eupati-reload/)

Region Zealand (https://kap-sjaelland.dk/)

 

Promotion
Success Story / Achievements: 

As part of the Danish innovation infrastructure, the national innovation network Biopeople has operated since 2005 from universities and university hospitals in Copenhagen, Aarhus and Aalborg.

Based on the national focus on personalised medicine the network provides a framework for knowledge sharing, matchmaking and collaboration between research groups at hospitals and universities and the research based bio- and life-science industry. Among other activities, this has resulted in working groups relating to personalised medicine, autoimmune diseases, bio imaging, x-omics and clinical research. Through membership of about 100 life-science companies Biopeople has a close connection to the Danish life science community, offering members to participate, co-organise or present at Biopeoples’ events.

Exposure and financial incentives

Biopeople continually focus on the exposure of small and medium sized life science companies and is happy to publish news about activities and the companies’ latest results in its newsletter, at the website and social media like LinkedIn. Biopeople participates in several EU projects including the recent Boost4Health project. These projects have offered an international network of expertise and minor financial incentives, to help Danish life science companies explore their international growth potential.

The story about GlycoDisplay

GlycoDisplay, a spinout company from the Danish National Research Foundation Excellence Center, Center for Glycomics at the University of Copenhagen, is an example of a company that Biopeople have supported through exposure. Biopeople published news about GlycoDisplay in 2016 before the company was even established, and again when it moved into the 10th floor at the bright new Maersk Tower, University of Copenhagen, in 2017.

GlycoDisplay initially offered its technology – to modify sugar structures on glyco proteins – to the pharmaceutical industry for the development of new medicines. Now three years after the establishment, the company, supported by Innovationsfonden, has identified a new concept, Long-Acting Glycodesign (LAGD), to improve enzymes for the treatment of rare genetic lysosomal diseases. In spring 2019 GlycoDisplay, together with researchers at the University of Copenhagen, published the first results of the LAGD concept for the treatment of Fabry disease in Nature Communications.

Relevant target group

”The collaboration with Biopeople has from the very first day been for the benefit of GlycoDisplay,” says Claus Kristensen, CEO and founder of GlycoDisplay. ”Biopeople has proven to provide a good platform for exposure when we have published new results and news as for instance the Nature Communications article in spring 2019. Coverage in Biopeoples’ newsletter has reached the desired target group. In 2018, we furthermore attended a large Boost4Health event, organised by Biopeople at the Maersk Tower. We got an opportunity to give the participants a tour of our facilities and to present GlycoDisplay for 60 Danish and international companies. The result for us was useful contacts and a new collaboration partner.”

GlycoDisplay’s technology now attracts international awareness. Most of the Company’s partner agreements are with American companies, and Weihua Tian, researcher at the University of Copenhagen and at GlycoDisplay, just received a Young Investigator Award to present the Long-Acting Glycodesign concept at WORLDSymposium 2020 in Orlando, USA. WORLDSymposium organise research within lysosomal diseases. Together with three academic groups, GlycoDisplay recently applied for a H2020 Synergy Grant, and the Company and a large European partner currently prepare a Eurostar application, which they will submit in 2020.

https://biopeople.eu/news/show/biopeople-catalyses-partnerships-and-innovation-in-biotech-manufacturing-a-danish-life-science-stron/

 

Why should partners choose you for cooperation?: 

Biopeople is the major Danish cluster organisation for Life Sciences with particular focus on pharmaceuticals, biotechnology and biomedical technology. Services and programmes include Catalyzing innovation by creating inspiring meeting places for public and private stakeholders within Life Sciences; Inspiring to cross disciplinary collaboration and partnership bringing smaller companies, public/private synergy and internationalization into the spotlight; Supporting the development of professional competences within especially internationalization, innovation and foresight

We offer the following:

Free network membership for companies
National and international network within the bio- and life science communities
Catalysing collaboration between researchers and companies (SMEs)
Guidance / feedback re. application for funds
Access to pitch training etc.
Collaborations and joint events
Knowledge sharing and matchmaking
Exposure of research/technology/company
Profile in Newsletter (>2.000 recipients, exposure at search platform Infomedia – press clippings)
Sharing of news at LinkedIn (>2.000 followers)
Speaker opportunities at events
Exhibition opportunities at events